MedPharm || طبصيدلة
رفتن به کانال در Telegram
شرح مادة الصيدلة السريرية clinical pharmacology 🧑🏻⚕️ معرف التلي: mohammedsalim10 Instagram: _a1mh
نمایش بیشترکشور مشخص نشده استدسته بندی مشخص نشده است
3 508
مشترکین
اطلاعاتی وجود ندارد24 ساعت
-147 روز
-5830 روز
آرشیو پست ها
3 507
Regarding pharmacologic therapy of dysmenorrhea, The first line pharmacologic therapy is :
3 507
A 23 years old female is diagnosed to have amenorrhea due to hyperprolactinemia. The drug of choice is :
3 507
In women with anovulatory bleeding with high androgen levels or signs of
hyperandrogenism, the recommended combined hormonal contraceptives (chcs) are the following except
3 507
14 age old female complains from crampy pelvic pain beginning shortly during menses. Pain radiates into lower back or thighs. Which of the following is the first-line therapy for dysmenorrhea?
3 507
A 23-year-old female complains of absence of menses (amenorrhea) over 3 months period. She experienced menarche at the age of 15 years. What is the first step in evaluating this complaint?
3 507
When is a levonorgestrel-releasing IUD considered a first-line treatment for
dysmenorrhea
3 507
Women with anovulatory bleeding from PCOS who are pursuing pregnancy. Women may be treated with
3 507
What is the recommended first-line therapy for patients with functional hypothalamic amenorrhea, according to the 2017 Endocrine Society Clinical Practice Guideline?
3 507
E.N; a 38 years old female‚ 95 Kg weight with hirsutism and central obesity‚ married
since 2022 with no children. This patient visits gynecological clinic suffering front heavy and
irregular menstrual bleeding.
All the following represent desired therapeutic outcomes for this patient EXCEPT:
a- Stop acute bleeding.
b- Restore natural cycle of endometrial growth and shedding.
c- Minimize the premature ovarian failure.
d- Decrease long-term complications of anovulation including infertility.
e- Improve patients quality of life
3 507
Which of the following statements concerning amenorrhea treatments do you believe to be false?
a- Metformin is an effective treatment for patients experiencing secondary amenorrhea.
b- Withdrawal bleeding is a prominent adverse effect of progestins administered to women
with secondary amenorrhea
c- For secondary amenorrhea‚ 10 mg of Medroxyprogesterone Acetate (MPA) orally twice daily for 7-10 days is the recommended dosage
d- Bromocriptine is the suitable treatment for amenorrhea caused by hyperprolactinemia in
women.
e- First-line treatment for people with functional hypothalamic amenorrhea no longer includes synthetic estrogen.
3 507
17-year-old girl with PCOS expresses concern about the long-term health risks
associated with her condition. Which of the following is NOT a potential long-term complication of untreated PCOS?
3 507
dysmenorrhea secondary to endometriosis‚ what is considered first line treatment.
3 507
regarding the treatment of dysmenorrhea‚ the first-line therapy for dysmenorrhea is
3 507
Which one of the following treatment is used for a women with amenorrhea secondary to hyperprolactinemia
3 507
Is the absence of menses for three cycles or 6 months in a previously menstruating woman.
3 507
All of the following involve in the management of dysmenorrhea except
3 507
Is pelvic pain, generally described as cramping, that occurs during or just prior to menstruation
